ARUNDEL, CATHERINE orcid.org/0000-0003-0512-4339, WELCH, CHARLIE orcid.org/0000-0002-2421-5538, Strachan, Luke orcid.org/0000-0003-1809-2516 et al. (22 more authors) (Accepted: 2026) Compression therapies for venous leg ulcers: The VENous Ulcer Study 6 (VenUS 6), an open, multicentre, randomised clinical trial. Plos medicine. ISSN: 1549-1277 (In Press)
Abstract
Background: Strong compression is a recommended first line venous leg ulcer treatment. With limited research comparing the clinical effectiveness of compression wraps and two-layer compression bandage treatments with evidence-based compression (four-layer compression bandages and two-layer compression hosiery), this study aimed to evaluate their clinical effectiveness on time to venous leg ulcer healing. Methods and Findings: A pragmatic, three-arm, randomised controlled trial in 33 United Kingdom primary, community and hospital sites between 03·02·2021 and 31·08·2024. Adults with a venous leg ulcer appropriate for compression therapy were randomised 1:1:1 to be offered compression wraps, two-layer compression bandage or evidence-based compression (two-layer hosiery or four-layer bandage). Participants and clinical staff were not blinded. The primary outcome was time to blind-assessed ulcer healing (date of ulcer healing: date of earliest photograph showing healing) . Analyses included a non-inferiority comparison of two-layer bandage and evidence-based compression (handling key intercurrent events under hypothetical and treatment policy strategies), and superiority comparisons of compression wraps with both evidence-based compression and two-layer bandage (handling key intercurrent events under a treatment policy strategy). Cox proportional hazards regression adjusted for fixed effects (treatment allocation, baseline ulcer area and duration, participant age, mobility status), and shared frailties (recruitment site). The trial was pre-registered: ISRCTN67321719. 637 participants were randomised to be offered compression wraps (n=213), two-layer bandage (n=211) or evidence-based compression (n=213). Mean age was 70·3 (range 24·6 to 97·0) years, 55% (n=351) were male, and the majority (n=606, 95%) were white. 633 participants contributed time at risk of healing and were included in the analysis. Using a treatment policy strategy to handle key intercurrent events (modified intention-to-treat analysis), the estimated hazard ratio for the non-inferiority comparison (evidence-based compression and two-layer bandaging) was 1.01 (95% CI [0.79, 1.28]), meeting the pre-specified non-inferiority margin of 1.33. The corresponding hypothetical strategy analysis gave a hazard ratio of 1.16 (95% CI [0.86,1.58]), which did not demonstrate non-inferiority. For the superiority comparisons, healing was slower in the compression wrap group than in the evidence-based compression group (HR 0.78, 95% CI [0.61, 1.00]; p=0.05). Results were similar for the two-layer bandage group (HR 0.79, 95% CI [0.61, 1.01]; p=0.06), although this did not reach statistical significance. Both comparisons showed considerable aleatoric uncertainty, with confidence intervals ranging from a 39% reduction in the hazard of healing to little or no difference between groups. Nine serious adverse events occurred; one potentially related to treatment (cause of death could not be ascertained). Departures from allocated compression treatment were common, which limits generalisability to settings with different adherence patterns. These departures, lower than expected ulcer healing incidence rates and slight under-recruitment, resulted in the number of healing events being smaller than the number required for 80% power. Conclusion: Compression wraps are unlikely to reduce the time to venous leg ulcer healing compared to two-layer bandage or evidence-based compression, although confidence intervals included treatment effects indicating little or no difference between groups. Despite remaining uncertainty, these findings may not support compression wraps as a first line strong compression treatment for venous leg ulcers. Trial Registration: ISRCTN – reference 67321719. Funding: United Kingdom National Institute for Health and Care Research (NIHR) Health Technology Assessment Programme (Project Reference: 128625).
Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Copyright, Publisher and Additional Information: | This is an author-produced version of the published paper. Uploaded in accordance with the University’s Research Publications and Open Access policy. |
| Dates: |
|
| Institution: | The University of York |
| Academic Units: | The University of York > Faculty of Sciences (York) > Health Sciences (York) The University of York > Faculty of Social Sciences (York) > Centre for Health Economics (York) |
| Funding Information: | Funder Grant number NETSCC NIHR128625 |
| Date Deposited: | 11 Jun 2026 15:00 |
| Last Modified: | 11 Jun 2026 15:00 |
| Status: | In Press |
| Refereed: | Yes |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:242008 |
Download
Filename: VenUS_6_Results_paper_v1.5_29.05.2026_Clean.docx
Description: VenUS 6 Results paper v1.5 29.05.2026_Clean
Licence: CC-BY 2.5

CORE (COnnecting REpositories)
CORE (COnnecting REpositories)